AstraZeneca says its vaccine should be effective against new coronavirus variant
Drugmakers are scrambling to test their COVID-19 vaccines against the new fast-spreading variant of the virus that is raging in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
AZD1222
AstraZeneca COVID-19 vaccine shows 90 per cent efficacy
AZD1222, given as a half dose, followed by a full dose at least one month apart, showed vaccine efficacy of 90 per cent while it…
UK MHRA commences accelerated review for AstraZeneca’s COVID-19 vaccine candidate
In rolling reviews, regulators can see clinical data in real-time and have discussions with pharma companies on manufacturing…
Oxford COVID-19 vaccine trials produce robust immune response in elderly: FT
AstraZeneca, which is developing the vaccine with Oxford University researchers, is seen as a frontrunner in the race to produce a…
Clinical trials of AstraZeneca-Oxford COVID-19 vaccine candidate resumes in UK
This is following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so
AstraZeneca stops COVID-19 vaccine trial due to unexplained illness in participant
A participant was found to have transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by…
Phase III trials of AstraZeneca COVID-19 vaccine candidate begins in US
AZD1222 is already undergoing late-stage clinical trials in Britain, Brazil and South Africa, with additional trials planned in…
AstraZeneca signs manufacturing pact with Chinese firm, BioKangtai for COVID-19 vaccine
As per the deal, AstraZeneca will deliver the first 100 million doses this year and 200 million doses by the end of 2021